<SEC-DOCUMENT>0001193125-18-315782.txt : 20181101
<SEC-HEADER>0001193125-18-315782.hdr.sgml : 20181101
<ACCEPTANCE-DATETIME>20181101162005
ACCESSION NUMBER:		0001193125-18-315782
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20181030
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181101
DATE AS OF CHANGE:		20181101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		181154020

	BUSINESS ADDRESS:	
		STREET 1:		ONE POST ST
		STREET 2:		MCKESSON PLAZA
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		4159838300

	MAIL ADDRESS:	
		STREET 1:		ONE POST ST
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d647762d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form&nbsp;8-K
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15(d) OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): October&nbsp;30, 2018 </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>McKesson Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>1-13252</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>94-3207296</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>One Post Street, San Francisco, California</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>94104</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (415)&nbsp;983-8300 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report.) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act
of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth
company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;30, 2018, John H. Hammergren decided to retire from his roles as
Chief Executive Officer and Chairman of the Board of Directors (the &#147;Board&#148;) of McKesson Corporation (the &#147;Company&#148;), effective as of March&nbsp;31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has appointed Brian S. Tyler, currently the Company&#146;s President and Chief Operating Officer, as Chief Executive Officer effective April&nbsp;1,
2019. The Board also expects to appoint Mr.&nbsp;Tyler to the Board effective April&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Tyler, age 51, has served as President and
Chief Operating Officer of the Company since August 2018, and previously served as Chairman of the Management Board of McKesson Europe AG since 2017. Mr.&nbsp;Tyler served as the Company&#146;s President and Chief Operating Officer of McKesson
Europe from 2016 to 2017, the Company&#146;s President of North American Pharmaceutical Distribution and Services from 2015 to 2016, and as the Company&#146;s Executive Vice President, Corporate Strategy&nbsp;&amp; Business Development from 2012 to
2015. Mr.&nbsp;Tyler previously served in various other leadership roles in the Company, including as President of U.S. Pharmaceutical, President of McKesson Medical-Surgical, and President of McKesson Specialty Health. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee of the Board has not yet determined Mr.&nbsp;Tyler&#146;s compensation for serving as the Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edward A. Mueller, the Company&#146;s current Lead Independent Director, has been appointed independent Chairman of the Board, effective April&nbsp;1, 2019.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Registrant&#146;s press release relating to these changes is being furnished as Exhibit 99.1 to this Current Report on Form&nbsp;8-K.
Exhibit 99.1 shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by
reference into any filing of the Registrant under the Securities Act of 1933 or the Exchange Act. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Exhibits. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d647762dex991.htm">Press release issued by the Company dated November 1, 2018. </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: November 1, 2018 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>McKesson Corporation</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lori A. Schechter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Lori A. Schechter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, General Counsel and Chief Compliance Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d647762dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g647762mckessonlogo.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JOHN HAMMERGREN ANNOUNCES RETIREMENT; BRIAN TYLER TO BECOME </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>McKESSON&#146;S CEO AND EDWARD MUELLER TO CHAIR BOARD </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SAN FRANCISCO&#151;November 1, 2018&#151;</B>McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer
(CEO), has decided to retire, effective March&nbsp;31, 2019. McKesson&#146;s Board of Directors has unanimously selected Brian Tyler, 51, currently president and chief operating officer (COO), to succeed Hammergren as CEO, effective April&nbsp;1,
2019. Tyler will also remain as president. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edward Mueller, 71, currently lead independent director on McKesson&#146;s Board of Directors, will succeed
Hammergren as an independent chairman of the Board, also effective April&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;It has been an honor to serve as McKesson&#146;s CEO for
nearly 20 years,&#148; Hammergren said. &#147;We are making solid progress with our strategic growth initiative and the company is in a strong financial position. This is the right time to turn the leadership reins over to the next generation and no
one is better equipped than Brian to lead McKesson into the future. He is a gifted leader with deep industry knowledge and an unwavering commitment to enhancing value for our customers and their patients.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Hammergren&#146;s leadership, McKesson has become the leading provider of healthcare services and information technology solutions that help
organizations across the healthcare industry improve their business performance and deliver better care. In the time since he became CEO on April&nbsp;1, 2001, the company has more than quadrupled revenues to $208&nbsp;billion, expanded into global
markets, and advanced to number six on the Fortune 500, reflecting total shareholder returns of more than 400% or 9% on a compound annual basis (as of October&nbsp;31, 2018). These results reflect significant outperformance compared to the S&amp;P
500 Health Care Index. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hammergren took over the company at a time of crisis and created its ICARE shared principles, which serve as the foundation for
McKesson&#146;s culture and values across the globe. Recognizing his tremendous track record of success, Harvard Business Review named Hammergren as one of their 100 &#147;Top Performing CEOs in the World.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;There are few leaders who have had such an impact on a company and on an entire industry,&#148; said Mueller. &#147;Over nearly two decades, John has
built one of the greatest organizations in healthcare&#151;a company that has had a <FONT STYLE="white-space:nowrap">far-reaching,</FONT> positive impact on patient care in every setting. On behalf of McKesson&#146;s entire Board, I want to thank
John for his countless contributions and tremendous leadership since assuming the CEO role.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brian Tyler to be new CEO&nbsp;&amp; President
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently president and COO of McKesson, Tyler is a <FONT STYLE="white-space:nowrap">21-year</FONT> McKesson veteran. He has led nearly every major
business within the company as well as McKesson&#146;s corporate strategy and business development unit. His previous McKesson leadership roles include: </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>McKesson Europe:</B> Tyler served as chairman of the Management Board (CEO) of McKesson Europe, where he drove
revenue growth to $27.3&nbsp;billion by focusing on operational excellence, collaboration and innovation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>North American Pharmaceutical Distribution Services:</B> He had overall leadership responsibility for
McKesson&#146;s pharmaceutical distribution and related businesses in North America, including McKesson U.S. Pharmaceutical, McKesson Canada, McKesson Specialty Health and McKesson Pharmacy Systems&nbsp;&amp; Automation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Corporate Strategy and Business Development:</B> Tyler served as executive vice president of Corporate
Strategy and Business Development where he led the overall corporate strategy for McKesson. Tyler helped guide strategy development across McKesson&#146;s business units as well as led the mergers and acquisitions function across the company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>U.S. Pharmaceutical:</B> He oversaw the business unit&#146;s operations and the distribution of
pharmaceuticals and other healthcare related products to customers in four primary segments: national and regional retail pharmacy chains; retail independent pharmacies; hospital providers; and mail pharmacy. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>McKesson Medical-Surgical:</B> He led the nation&#146;s largest alternate site distributor to physician
offices, long-term care facilities, surgery centers, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">direct-to-patient</FONT></FONT> home care and occupational health, and employers. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>McKesson Specialty Care Solutions:</B> Tyler served as president with responsibility for distribution,
logistics and pharmacy operations, marketing services, and Prospective Health, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>McKesson Distribution Solutions: </B>He joined the company as vice president of strategy and business
development for McKesson Distribution Solutions in 1997. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Brian is the ideal leader to guide McKesson through the next era,&#148;
said Mueller. &#147;Having spent his entire career in healthcare, he has a strong point of view on the future of the industry, both in the U.S. and globally, as well as how McKesson will continue to play an integral role in improving care while
driving value for McKesson&#146;s shareholders.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tyler earned his Ph.D. and M.A. from the University of Chicago, Department of Economics in 1994,
where he studied under a grant from the National Science Foundation, and earned his B.A. in economics with high honors from the University of California Santa Cruz in 1989. Prior to joining McKesson, he spent three years at Integral, Inc. as a
senior associate, Health Care Consulting in Cambridge, MA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ed Mueller to be new Chairman of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mueller, currently lead independent director on McKesson&#146;s Board of Directors, will provide strong leadership continuity for McKesson as chairman of the
company&#146;s Board of Directors. He has been a director of McKesson since April 2008 and has served as the lead independent director since July 2013. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Ed Mueller will be a terrific chairman of our Board of Directors,&#148; said Hammergren. &#147;During his 10 years of service on our Board, Ed has
developed a deep knowledge of McKesson and our industry. He has the respect of our board, McKesson&#146;s leaders and our investors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mueller held
the position of chairman and chief executive officer of Qwest Communications from August 2007 to April 2011. He has also served as chief executive officer of Williams-Sonoma, Inc. and Ameritech Corporation, a subsidiary of SBC Communications. He was
formerly a director of The Clorox Company, CenturyLink, Inc., Williams-Sonoma, Inc. and VeriSign, Inc. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The entire Board will work closely with Hammergren, Tyler and Mueller over the coming months to ensure a
smooth transition. Hammergren will remain chairman of the Board for Change Healthcare and will continue to support McKesson in an advisory capacity after his retirement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About McKesson Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">McKesson Corporation,
currently ranked 6<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information
technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the
right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful &#151; all for the better health of patients.
McKesson has been named the &#147;<U>Most Admired Company</U>&#148; in the healthcare wholesaler category by FORTUNE, a &#147;<U>Best Place to Work</U>&#148; by the Human Rights Campaign Foundation, and a top <U>military-friendly company</U> by
Military Friendly. For more information, visit&nbsp;<U>www.mckesson.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contacts: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Craig Mercer, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">415-983-8391</FONT></FONT> (Investors and Financial Media) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Craig.Mercer@McKesson.com</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kristin Chasen, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-983-8974</FONT></FONT> (General and Business Media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Kristin.Chasen@McKesson.com</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g647762mckessonlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g647762mckessonlogo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (" @(" 0(" @(# @(# P8$ P,#
M P<%!00&" <)" @'" @)"@T+"0H,"@@("P\+# T.#@\."0L0$1 .$0T.#@[_
MVP!# 0(# P,# P<$! <."0@)#@X.#@X.#@X.#@X.#@X.#@X.#@X.#@X.#@X.
M#@X.#@X.#@X.#@X.#@X.#@X.#@X.#@[_P  1"  H 0<# 2(  A$! Q$!_\0
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MDCP;\%O&_P >+[2_C1J,=C8K:*VDV\UV]M%<2Y.X-(I 7 P?F(!KJRO+,)'
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M?MW> [[X#ZYX/^%EQ+K.N:M;/9SWLD12&V@D&V0@_P 3%2P&",$@\]*_._\
M9E^%>H?%K]KWPOH,=JUSI=O>I=ZO*1D+;HP9\GH"P! ]34Y%AZF P=:MB$XI
MK2^A7$.)I9GCJ-##OF:>MO,_4_\ ;PW?\.J-#WYW?VGIV?\ OT]?GO\ L2^
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M#CZ7!+L^2-FCVEL9Z9)/XT45K6Q^*KPA&<KJ&QCA\MP5"<Y4XV<]SX0^#O[
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M_P" 1_\ BZ**Z,/FV.PD'3I2LF[['-B\CR_&34JT6VE;<;_P[*\9?]#]8?\
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?_P">?ZT445R5:LZ]1U)N[>YZ&%HT\-0C2IJT5L?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
